A Cost Analysis of Fondaparinux Versus Enoxaparin in Total Knee Arthroplasty

2004 ◽  
Vol 11 (1) ◽  
pp. 3-8 ◽  
Author(s):  
William J. Spruill ◽  
William E. Wade ◽  
Ryan B. Leslie
2018 ◽  
Vol 33 (2) ◽  
pp. 320-323 ◽  
Author(s):  
Ali H. Sobh ◽  
Matthew P. Siljander ◽  
Anthony J. Mells ◽  
Denise M. Koueiter ◽  
Drew D. Moore ◽  
...  

10.29007/h8xz ◽  
2019 ◽  
Author(s):  
Christina Cool ◽  
David Jacofsky ◽  
Kelly Seeger ◽  
Andréa Coppolecchia ◽  
Nipun Sodhi ◽  
...  

IntroductionOne way to potentially help contain the rising healthcare costs is the utilization of technological advances, such as robotic-assistive technology, for total knee arthroplasty (TKA). Therefore, the purpose of this study was to perform a cost analysis between robotic-arm assisted TKA and manual TKA (mTKA) techniques. Specifically, we compared: 1) 90-day EOC costs, as well as several variables within the episode, including 2) index costs; 3) index lengths-of-stay (LOS); 4) discharge disposition; and 5) readmission rates.MethodsA retrospective claims analysis was performed on Medicare FFS beneficiaries who underwent rTKA and mTKA procedures between January 1, 2016 and March 31, 2017. Patients were matched rTKA to mTKA in a 1-to-5 ratio, yielding 519 rTKAs and 2,595 mTKAs. The overall 90-day EOC costs, including the index procedures, LOS, discharge dispositions, and readmissions were compared between cohorts.ResultsOverall 90-day EOC costs ($18,568 vs. $20,960) as well as index facility costs ($12,384 vs. $13,024; p=0.0001) were found to be less than that for rTKA vs. mTKA. rTKA also accrued $1,744 fewer costs than mTKA (5,234 vs. $6,978; p=<0.0001) utilized fewer days in inpatient (4 vs. 7; p<0.0001) and SNF care (15 vs. 16; p=0.0642) as well as a 90-day readmission reduction of 33% (p=0.0423).DiscussionThe results from this study show rTKA to be associated with significantly lower 90-day EOC costs. These lower rTKA patient costs are likely attributable to the significantly lower index costs, increased likelihood of being discharged to home, shorter LOS, and decreased readmission rates, when compared to mTKA patient costs.


2015 ◽  
Vol 30 (12) ◽  
pp. 2271-2274 ◽  
Author(s):  
Geoffrey W. Siegel ◽  
Neil N. Patel ◽  
Michael A. Milshteyn ◽  
David Buzas ◽  
Daniel J. Lombardo ◽  
...  

2014 ◽  
Vol 31 (2) ◽  
pp. 149-153 ◽  
Author(s):  
Mustafa Gokhan Bilgili ◽  
Ersin Ercin ◽  
Gokhan Peker ◽  
Cemal Kural ◽  
Serdar Hakan Basaran ◽  
...  

2019 ◽  
Vol 8 (5) ◽  
pp. 327-336 ◽  
Author(s):  
Christina L Cool ◽  
David J Jacofsky ◽  
Kelly A Seeger ◽  
Nipun Sodhi ◽  
Michael A Mont

Author(s):  
Robert Brochin ◽  
Jashvant Poeran ◽  
Khushdeep S. Vig ◽  
Aakash Keswani ◽  
Nicole Zubizarreta ◽  
...  

AbstractGiven increasing demand for primary knee arthroplasties, revision surgery is also expected to increase, with periprosthetic joint infection (PJI) a main driver of costs. Recent data on national trends is lacking. We aimed to assess trends in PJI in total knee arthroplasty revisions and hospitalization costs. From the National Inpatient Sample (2003–2016), we extracted data on total knee arthroplasty revisions (n = 782,449). We assessed trends in PJI prevalence and (inflation-adjusted) hospitalization costs (total as well as per-day costs) for all revisions and stratified by hospital teaching status (rural/urban by teaching status), hospital bed size (≤299, 300–499, and ≥500 beds), and hospital region (Northeast, Midwest, South, and West). The Cochran–Armitage trend test (PJI prevalence) and linear regression determined significance of trends. PJI prevalence overall was 25.5% (n = 199,818) with a minor increasing trend: 25.3% (n = 7,828) in 2003 to 28.9% (n = 19,275) in 2016; p < 0.0001. Median total hospitalization costs for PJI decreased slightly ($23,247 in 2003–$20,273 in 2016; p < 0.0001) while median per-day costs slightly increased ($3,452 in 2003–$3,727 in 2016; p < 0.0001), likely as a function of decreasing length of stay. With small differences between hospitals, the lowest and highest PJI prevalences were seen in small (≤299 beds; 22.9%) and urban teaching hospitals (27.3%), respectively. In stratification analyses, an increasing trend in PJI prevalence was particularly seen in larger (≥500 beds) hospitals (24.4% in 2003–30.7% in 2016; p < 0.0001), while a decreasing trend was seen in small-sized hospitals. Overall, PJI in knee arthroplasty revisions appears to be slightly increasing. Moreover, increasing trends in large hospitals and decreasing trends in small-sized hospitals suggest a shift in patients from small to large volume hospitals. Decreasing trends in total costs, alongside increasing trends in per-day costs, suggest a strong impact of length of stay trends and a more efficient approach to PJI over the years (in terms of shorter length of stay).


Author(s):  
Jung-Won Lim ◽  
Yong-Beom Park ◽  
Dong-Hoon Lee ◽  
Han-Jun Lee

AbstractThis study aimed to evaluate whether manipulation under anesthesia (MUA) affect clinical outcome including range of motion (ROM) and patient satisfaction after total knee arthroplasty (TKA). It is hypothesized that MUA improves clinical outcomes and patient satisfaction after primary TKA. This retrospective study analyzed 97 patients who underwent staged bilateral primary TKA. MUA of knee flexion more than 120 degrees was performed a week after index surgery just before operation of the opposite site. The first knees with MUA were classified as the MUA group and the second knees without MUA as the control group. ROM, Knee Society Knee Score, Knee Society Functional Score, Western Ontario and McMaster Universities (WOMAC) score, and patient satisfaction were assessed. Postoperative flexion was significantly greater in the MUA group during 6 months follow-up (6 weeks: 111.6 vs. 99.8 degrees, p < 0.001; 3 months: 115.9 vs. 110.2 degrees, p = 0.001; 6 months: 120.2 vs. 117.0 degrees, p = 0.019). Clinical outcomes also showed similar results with knee flexion during 2 years follow-up. Patient satisfaction was significantly high in the MUA group during 12 months (3 months: 80.2 vs. 71.5, p < 0.001; 6 months: 85.8 vs. 79.8, p < 0.001; 12 months: 86.1 vs. 83.9, p < 0.001; 24 months: 86.6 vs. 85.5, p = 0.013). MUA yielded improvement of clinical outcomes including ROM, and patient satisfaction, especially in the early period after TKA. MUA in the first knee could be taken into account to obtain early recovery and to improve patient satisfaction in staged bilateral TKA.


Sign in / Sign up

Export Citation Format

Share Document